Compare CRNX & IBOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRNX | IBOC |
|---|---|---|
| Founded | 2008 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.2B |
| IPO Year | 2018 | N/A |
| Metric | CRNX | IBOC |
|---|---|---|
| Price | $55.90 | $70.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | $73.70 | ★ $85.00 |
| AVG Volume (30 Days) | ★ 1.6M | 247.5K |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 1.99% |
| EPS Growth | N/A | ★ 5.13 |
| EPS | N/A | ★ 6.76 |
| Revenue | $1,535,000.00 | ★ $821,716,000.00 |
| Revenue This Year | $425.41 | N/A |
| Revenue Next Year | $943.30 | N/A |
| P/E Ratio | ★ N/A | $10.41 |
| Revenue Growth | ★ 47.74 | 2.80 |
| 52 Week Low | $24.10 | $54.11 |
| 52 Week High | $57.99 | $73.66 |
| Indicator | CRNX | IBOC |
|---|---|---|
| Relative Strength Index (RSI) | 65.78 | 56.98 |
| Support Level | $53.45 | $67.78 |
| Resistance Level | $56.23 | $71.29 |
| Average True Range (ATR) | 3.09 | 1.59 |
| MACD | 0.60 | 0.15 |
| Stochastic Oscillator | 84.22 | 84.76 |
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
International Bancshares Corp is a multibank financial holding company. The company provides commercial and retail banking services in Texas and Oklahoma. The services provided by the bank include checking, savings, bank cards, lending, insurance, mortgage, investments, and other services.